Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00039507 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00039507: Completed Phase 2 study, sponsored by Fox Chase Cancer Center.
NCT00039507 is a Phase 2 study that has completed, run by Fox Chase Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00039507, a Phase 2 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining radiofrequency ablation with surgery in treating patients who have stage I or stage II non-small cell lung cancer.
Interventions
- PROCEDURE conventional surgery
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-06 |
| Est. Completion | 2004-02 |
| Phase | Phase 2 |
What the finished NCT00039507 record still lists
NCT00039507 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00039507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00039507 about?
NCT00039507 is a clinical study titled "Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer". RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining radiofrequency ablation with surgery in treating patients who have s...
What is the current status of trial NCT00039507?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-06. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00039507?
The interventions under investigation include: conventional surgery (PROCEDURE), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00039507?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia